Incidence, risk factors and prediction of post-operative acute kidney injury following cardiac surgery for active infective endocarditis: An observational study

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Legrand, Matthieu ^a,b   Pirracchio, Romain ^a,c,d   Rosa, Anne ^a   Petersen, Maya L ^d   Van der Laan, Mark ^d   Fabiani, Jean Noël ^e   Fernandez gerlinger, Marie paule ^e   Podglajen, Isabelle ^e   Safran, Denis ^a   Cholley, Bernard ^a   Mainardi, Jean Luc ^e  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CONTRAST MEDIUM; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIOPULMONARY BYPASS; DISEASE COURSE; FEMALE; HEART SURGERY; HUMAN; INCIDENCE; KIDNEY FUNCTION; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; TREATMENT OUTCOME; ACUTE KIDNEY INJURY; ENDOCARDITIS; FRANCE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE; RETROSPECTIVE STUDY;

ACUTE KIDNEY INJURY; ADULT; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; ENDOCARDITIS; FEMALE; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84886140123     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13041     Document Type: Article

References (35)

1. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG, Corey GR, Chu VH, Fenely M, Pachirat O, Tan R-S, Watkin R, Ionac A, Moreno A, Mestres CA, Casabé J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 2010, 121:1005-1013. 10.1161/CIRCULATIONAHA.109.864488, 3597944, 20159831.
2. Palomba H, de Castro I, Neto ALC, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int 2007, 72:624-631. 10.1038/sj.ki.5002419, 17622275.
3. Dasta JF, Kane-Gill SL, Durtschi AJ, Pathak DS, Kellum JA. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008, 23:1970-1974. 10.1093/ndt/gfm908, 18178605.
4. Englberger L, Suri RM, Li Z, Dearani JA, Park SJ, Sundt TM, Schaff HV. Validation of clinical scores predicting severe acute kidney injury after cardiac surgery. Am J Kidney Dis 2010, 56:623-631. 10.1053/j.ajkd.2010.04.017, 20630639.
5. Ho J, Reslerova M, Gali B, Nickerson PW, Rush DN, Sood MM, Bueti J, Komenda P, Pascoe E, Arora RC, Rigatto C. Serum creatinine measurement immediately after cardiac surgery and prediction of acute kidney injury. Am J Kidney Dis 2012, 59:196-201. 10.1053/j.ajkd.2011.08.023, 21967775.
6. Li S, Krawczeski CD, Zappitelli M, Devarajan P, Thiessen-Philbrook H, Coca SG, Kim RW, Parikh CR. Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study. Crit Care Med 2011, 39:1493-1499. 10.1097/CCM.0b013e31821201d3, 3286600, 21336114.
7. Parikh CR, Devarajan P, Zappitelli M, Sint K, Thiessen-Philbrook H, Li S, Kim RW, Koyner JL, Coca SG, Edelstein CL, Shlipak MG, Garg AX, Krawczeski CD. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011, 22:1748-1757. 10.1681/ASN.2010121302, 3171945, 21836143.
8. Conlon PJ, Jefferies F, Krigman HR, Corey GR, Sexton DJ, Abramson MA. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol 1998, 49:96-101.
9. Alonso-Valle H, Fariñas-Alvarez C, García-Palomo JD, Bernal JM, Martín-Durán R, Gutiérrez Díez JF, Revuelta JM, Fariñas MC. Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period. J Thorac Cardiovasc Surg 2010, 139:887-893. 10.1016/j.jtcvs.2009.05.042, 19660339.
10. Karth G, Koreny M, Binder T, Knapp S, Zauner C, Valentin A, Honninger R, Heinz G, Siostrzonek P. Complicated infective endocarditis necessitating ICU admission: clinical course and prognosis. Crit Care 2002, 6:149-154. 10.1186/cc1474, 111181, 11983041.
11. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638. 10.1086/313753, 10770721.
12. Cruz DN, Bagshaw SM, Ronco C, Ricci Z. Acute kidney injury: classification and staging. Contrib Nephrol 2010, 164:24-32.
13. Van der Laan MJ, Polley EC, Hubbard AE. Super learner. Stat Appl Genet Mol Biol 2007, 6:Article25.
14. Breiman L. Stacked regressions. Mach Learn 1996, 24:49-64.
15. Van der Laan MJ, Polley EC, Hubbard AE. Super learner. Statistical Applications in Genetics and Molecular Biology, Volume 6, Issue 1 2007, 1544-6115. ISSN (Online), doi:10.2202/1544-6115.1309.
16. Van der Laan MJ. Targeted maximum likelihood based causal inference: Part I. Int J Biostat 2010, 6:Article 2.
17. Van der Laan MJ. Targeted maximum likelihood based causal inference: Part II. Int J Biostat 2010, 6:Article 3.
18. Wang H, van der Laan MJ. Dimension reduction with gene expression data using targeted variable importance measurement. BMC Bioinforma 2011, 12:312.
19. Kang D-H, Kim Y-J, Kim S-H, Sun BJ, Kim D-H, Yun S-C, Song J-M, Choo SJ, Chung C-H, Song J-K, Lee J-W, Sohn D-W. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012, 366:2466-2473. 10.1056/NEJMoa1112843, 22738096.
20. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods M-C, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2007, 28:196-203.
21. Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M, Dupuis J-Y, Fremes SE, Kent B, Laflamme C, Lamy A, Legare J-F, Mazer CD, McCluskey SA, Rubens FD, Sawchuk C, Beattie WS. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009, 119:495-502. 10.1161/CIRCULATIONAHA.108.786913, 19153273.
22. Karkouti K, Wijeysundera DN, Beattie WS. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008, 117:478-484. 10.1161/CIRCULATIONAHA.107.718353, 18172032.
23. Legrand M, Mik EG, Johannes T, Payen D, Ince C. Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 2008, 14:502-516. 2386087, 18488066.
24. Legrand M, Mik EG, Balestra GM, Lutter R, Pirracchio R, Payen D, Ince C. Fluid resuscitation does not improve renal oxygenation during hemorrhagic shock in rats. Anesthesiology 2010, 112:119-127. 10.1097/ALN.0b013e3181c4a5e2, 19996951.
25. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006, 17:17-25.
26. Bosso JA, Nappi J, Rudisill C, Wellein M, Bookstaver PB, Swindler J, Mauldin PD. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother 2011, 55:5475-5479. 10.1128/AAC.00168-11, 3232787, 21947388.
27. Lodise TP, Lomaestro B, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 2008, 52:1330-1336. 10.1128/AAC.01602-07, 2292536, 18227177.
28. Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006, 355:653-665. 10.1056/NEJMoa053783, 16914701.
29. Gould FK. Linezolid: safety and efficacy in special populations. J Antimicrob Chemother 2011, 66:iv3-iv6. 10.1093/jac/dkr071, 21521705.
30. Falagas ME, Matthaiou DK, Bliziotis IA. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials. J Antimicrob Chemother 2006, 57:639-647. 10.1093/jac/dkl044, 16501057.
31. Buchholtz K, Larsen CT, Hassager C, Bruun NE. Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. Clin Infect Dis 2009, 48:65-71. 10.1086/594122, 19046065.
32. Leibovici L. Aminoglycoside-containing antibiotic combinations for the treatment of bacterial endocarditis: an evidence-based approach. Int J Antimicrob Agents 2010, 36:S46-S49.
33. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, JRybak M, Talan DA, Chambers HF. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011, 52:18-55.
34. Gálvez-Acebal J, Rodríguez-Baño J, Martínez-Marcos FJ, Reguera JM, Plata A, Ruiz J, Marquez M, Lomas JM, de la Torre-Lima J, Hidalgo-Tenorio C, de Alarcón A. Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort. BMC Infect Dis 2010, 10:17. 10.1186/1471-2334-10-17, 2822778, 20096116.
35. Dudoit S, Van Der Laan MJ. Asymptotics of cross-validated risk estimation in estimator selection and performance assessment 2003, http://biostats.bepress.com/ucbbiostat/paper126/.